Canadian VIGOUR Centre @cvcualberta.bsky.social · 17/06/2026Current PAH treatments improve outcomes, but remission remains a critical gap. Experts call for novel biomarkers, refined trial designs, & targeting reverse remodeling to optimize patient care. Learn about this research & more in our 2025 Annual Report ➡️: thecvc.ca/annual-repor... 000
Canadian VIGOUR Centre @cvcualberta.bsky.social · 05/06/2026A recent retrospective cohort study explored the frequency of elevated biomarkers & new clinical cardiac diagnoses in patients hospitalized with influenza or Covid-19. Learn about this research & more in our 2025 Annual Report ➡️: thecvc.ca/annual-repor... 000
Canadian VIGOUR Centre @cvcualberta.bsky.social · 08/05/2026The spring issue of the Canadian Cardiac Chronicle Newsletter is now available! Read more about our current trials, research highlights, & other recent news & updates here ➡️: tinyurl.com/65fbuvfa 000
Canadian VIGOUR Centre @cvcualberta.bsky.social · 29/04/2026In this highlighted review, Dr. Sean van Diepen & co-authors examine epidemiological data to propose a framework for the classification & management of mixed cardiogenic shock. Learn about this research & more in our 2025 Annual Report: thecvc.ca/annual-repor... 000
Canadian VIGOUR Centre @cvcualberta.bsky.social · 16/04/2026The STRIVE trial found low-dose alteplase does not reduce microvascular obstruction in high-risk STEMI patients. With no clinical advantage & potential safety risks, routine use is not recommended. Learn about this research & more in our 2025 Annual Report ➡️: thecvc.ca/annual-repor... 000
Canadian VIGOUR Centre @cvcualberta.bsky.social · 07/04/2026Currently accepting applications for the CVC Scholar Program! 🔬 This program is a unique training opportunity to enhance your research expertise & career in cardiovascular medicine. Learn more & apply here: thecvc.ca/programs-and... #CardioSky 001
Canadian VIGOUR Centre @cvcualberta.bsky.social · 23/03/2026Alberta data shows maternal asthma increases risks of preterm birth, low birth weight, & C-sections—with highest risks tied to active asthma & specific inflammatory phenotypes. Learn about this research & more in our 2025 Annual Report ➡️: thecvc.ca/annual-repor... 010
Canadian VIGOUR Centre @cvcualberta.bsky.social · 12/03/2026New meta-analysis data suggests rethinking transfusion strategies for patients with heart attack & anemia. Restrictive strategies were linked to higher cardiac mortality & lower 6-month survival. Learn about this research & more in our 2025 Annual Report: thecvc.ca/annual-repor... 000
Canadian VIGOUR Centre @cvcualberta.bsky.social · 05/03/2026Pooled data from the VICTOR & VICTORIA trials demonstrates vericiguat reduces CV death & HF hospitalizations across the HFrEF spectrum—from stable to recently worsened cases. Learn about this research & other highlights in the 2025 CVC Annual Report: thecvc.ca/annual-repor... 000
Canadian VIGOUR Centre @cvcualberta.bsky.social · 18/02/2026We’re pleased to share our 2025 Annual Report: The Arteries of Innovation. Innovation thrives on the circulation of diverse ideas. Discover how the CVC translates high-quality data into clinical solutions bridging the gap from discovery to care. Read the report here➡️: thecvc.ca/annual-repor... 000
Canadian VIGOUR Centre @cvcualberta.bsky.social · 16/12/2025The winter issue of the Canadian Cardiac Chronicle Newsletter is now available! Read more about our current trials, research highlights, & other recent news & updates here: mailchi.mp/bed47c9edc60... 010
Canadian VIGOUR Centre @cvcualberta.bsky.social · 27/11/2025Now accepting applications! The CVC Scholar Program is a unique training opportunity for early-stage investigators focused on cardiovascular disease research. Learn more & apply ➡️: thecvc.ca/programs-and... #cardiosky #cardiology 010
Canadian VIGOUR Centre @cvcualberta.bsky.social · 08/10/2025❣️The Fall 2025 issue of the CVC Chronicle newsletter is now available❣️ Read about our current trials, research highlights, & other recent news/updates here: tinyurl.com/3w4srx67 010
Canadian VIGOUR Centre @cvcualberta.bsky.social · 18/09/2025New analysis published in @jcardfail.bsky.social: applying the 5-STAR risk stratification method to VICTORIA trial data revealed a greater treatment effect for vericiguat on the composite endpoint of CV death or HF hospitalization. Read more ➡️: authors.elsevier.com/a/1llYy3pkRz... 010
Canadian VIGOUR Centre @cvcualberta.bsky.social · 21/08/2025The AURORA study is currently recruiting adults & adolescents with type 1 diabetes (T1D) & caregivers for an advisory group. Share your experience navigating the Alberta healthcare system & help us create a vital T1D knowledge hub! Learn more ➡️: thecvc.ca/aurora-recru... 010
Canadian VIGOUR Centre @cvcualberta.bsky.social · 15/07/2025New in @jaccjournals.bsky.social: A secondary analysis of the VICTORIA trial investigates the impact of geographic variation and Human Development Index on heart failure outcomes. 🫀 🌏 Read more here: www.sciencedirect.com/science/arti... 010
Canadian VIGOUR Centre @cvcualberta.bsky.social · 15/05/2025❣️The Spring 2025 issue of the CVC Chronicle newsletter is now available ❣️ Read about our current trials, research highlights, & other recent news/updates here: mailchi.mp/3fed258d1c05... 000
Canadian VIGOUR Centre @cvcualberta.bsky.social · 13/05/2025New research: Women with asthma, particularly active asthma, are at higher risk for preterm birth, low birth weight, & C-section. These findings highlight the need for improved asthma monitoring & management during pregnancy. @wchriuofa.bsky.social Read here: www.sciencedirect.com/science/arti... 022
Canadian VIGOUR Centre @cvcualberta.bsky.social · 18/03/2025We are pleased to share our 2024 Annual Report: ⚙️Research in Motion⚙️ The CVC is committed to advancing cardiovascular research, recognizing that each step in the process drives meaningful developments & enhances health outcomes for current & future generations. Read here: thecvc.ca/2024-annual-... 000